Founded Date: 2020-01-01
Technology: Immunotherapy
Funding Status: Seed
Total Funding: 120000.0
Employee Number: 1-10
Headquarters: Boston, Massachusetts, United States
Last Funding Date: 2020-01-17
Investors Number: 1.0
Last Funding Type: Pre-Seed
Estimated Revenue: $1M to $10M
Industry: Early Drug Development